Peptide record

TPDB10857

Cathelicidin CATH3 Pc-CATH1 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
26 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10857
Cathelicidin CATH3 Pc-CATH1
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP Peptipedia AFP-GFuse Antifp Antifungipept CAFPdb APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0 DBAASP
standard
No
A 26-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
RIKRFWPVVIRTVVAGYNLYRAIKKK
Physicochemical Analysis
C151H248N44O31
DCEQHMS
RKV
3175.91
12.01
8
0
14
+8
1.81
-0.108
112.31
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
8480
267.01
4
Residue Composition
number
2
A
4
R
1
N
0
D
0
C
0
E
0
Q
1
G
0
H
3
I
1
L
4
K
0
M
1
F
1
P
0
S
1
T
1
W
2
Y
4
V
Amino Acid Distribution
A: 2 R: 4 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 3 L: 1 K: 4 M: 0 F: 1 P: 1 S: 0 T: 1 W: 1 Y: 2 V: 4
Chemical Descriptors
26
C151H248N44O31
3175.91
12.01
+8
1.81
-0.108
Evidence Records 82 records
Evidence 1 Activity

Activity

MIC
Antibacterial
0.18-2.95 µM

Target

Staphylococcus aureus multiple strains

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM),
Evidence 2 Activity

Activity

MIC
Antibacterial
2.95 µM

Target

Staphylococcus epidermidis

Source & Reference

dbAMP

Other

Active against Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E.
Evidence 3 Activity

Activity

MIC
Antibacterial
0.09 µM

Target

Staphylococcus haemolyticus

Source & Reference

dbAMP

Other

gainst Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes
Evidence 4 Activity

Activity

MIC
Antibacterial
0.74 µM

Target

N. asteroids

Source & Reference

dbAMP

Other

strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gr
Evidence 5 Activity

Activity

MIC
Antibacterial
2.95 µM

Target

E. facalis

Source & Reference

dbAMP

Other

S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 u
Evidence 6 Activity

Activity

MIC
Antibacterial
1.48 µM

Target

E. faecium

Source & Reference

dbAMP

Other

uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumanni
Evidence 7 Activity

Activity

MIC
Antibacterial
0.74 µM

Target

P. acnes ATCC11827

Source & Reference

dbAMP

Other

0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (M
Evidence 8 Activity

Activity

MIC
Antibacterial
11.8 µM

Target

Klebsiella oxytoca

Source & Reference

dbAMP

Other

facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC
Evidence 9 Activity

Activity

MIC
Antibacterial
1.48 µM

Target

A. baumannii

Source & Reference

dbAMP

Other

IC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strai
Evidence 10 Activity

Activity

MIC
Antibacterial
0.74 µM

Target

Stenotrophomonas maltophilia

Source & Reference

dbAMP

Other

827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli
Evidence 11 Activity

Activity

MIC
Antibacterial
2.95 µM

Target

Stenotrophomonas maltophilia

Source & Reference

dbAMP

Other

ytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.9
Evidence 12 Activity

Activity

MIC
Antibacterial
1.48-5.9 µM

Target

Pseudomonas aeruginosa multiple strains

Source & Reference

dbAMP

Other

, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.
Evidence 13 Activity

Activity

MIC
Antibacterial
0.74-2.95 µM

Target

Escherichia coli multiple strains

Source & Reference

dbAMP

Other

0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabili
Evidence 14 Activity

Activity

MIC
Antibacterial
1.48-5.9 µM

Target

Klebsiella pneumoniae multiple strains

Source & Reference

dbAMP

Other

ruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi
Evidence 15 Activity

Activity

MIC
Antibacterial
23.6 µM

Target

P. vulgaris

Source & Reference

dbAMP

Other

li multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.1
Evidence 16 Activity

Activity

MIC
Antibacterial
1.48 µM

Target

P. mirabilis

Source & Reference

dbAMP

Other

74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0
Evidence 17 Activity

Activity

MIC
Antibacterial
11.8 µM

Target

S. typhi

Source & Reference

dbAMP

Other

ultiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (
Evidence 18 Activity

Activity

MIC
Antibacterial
0.37 µM

Target

A. cinerea

Source & Reference

dbAMP

Other

lis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (MIC 23.6 uM).
Evidence 19 Activity

Activity

MIC
Antibacterial
23.6 µM

Target

C. neoformans

Source & Reference

dbAMP

Other

i (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (MIC 23.6 uM).
Evidence 20 Activity

Activity

MIC
Antifungal
0.18-2.95 µM

Target

Staphylococcus aureus multiple strains

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM),
Evidence 21 Activity

Activity

MIC
Antifungal
2.95 µM

Target

Staphylococcus epidermidis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Active against Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E.
Evidence 22 Activity

Activity

MIC
Antifungal
0.09 µM

Target

Staphylococcus haemolyticus

Source & Reference

dbAMP CAFPdb Antifungipept

Other

gainst Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes
Evidence 23 Activity

Activity

MIC
Antifungal
0.74 µM

Target

N. asteroids

Source & Reference

dbAMP CAFPdb Antifungipept

Other

strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gr
Evidence 24 Activity

Activity

MIC
Antifungal
2.95 µM

Target

E. facalis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 u
Evidence 25 Activity

Activity

MIC
Antifungal
1.48 µM

Target

E. faecium

Source & Reference

dbAMP CAFPdb Antifungipept

Other

uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumanni
Evidence 26 Activity

Activity

MIC
Antifungal
0.74 µM

Target

P. acnes ATCC11827

Source & Reference

dbAMP CAFPdb Antifungipept

Other

0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (M
Evidence 27 Activity

Activity

MIC
Antifungal
11.8 µM

Target

Klebsiella oxytoca

Source & Reference

dbAMP CAFPdb Antifungipept

Other

facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC
Evidence 28 Activity

Activity

MIC
Antifungal
1.48 µM

Target

A. baumannii

Source & Reference

dbAMP CAFPdb Antifungipept

Other

IC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strai
Evidence 29 Activity

Activity

MIC
Antifungal
0.74 µM

Target

Stenotrophomonas maltophilia

Source & Reference

dbAMP CAFPdb Antifungipept

Other

827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli
Evidence 30 Activity

Activity

MIC
Antifungal
2.95 µM

Target

Stenotrophomonas maltophilia

Source & Reference

dbAMP CAFPdb Antifungipept

Other

ytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.9
Evidence 31 Activity

Activity

MIC
Antifungal
1.48-5.9 µM

Target

Pseudomonas aeruginosa multiple strains

Source & Reference

dbAMP CAFPdb Antifungipept

Other

, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.
Evidence 32 Activity

Activity

MIC
Antifungal
0.74-2.95 µM

Target

Escherichia coli multiple strains

Source & Reference

dbAMP CAFPdb Antifungipept

Other

0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabili
Evidence 33 Activity

Activity

MIC
Antifungal
1.48-5.9 µM

Target

Klebsiella pneumoniae multiple strains

Source & Reference

dbAMP CAFPdb Antifungipept

Other

ruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi
Evidence 34 Activity

Activity

MIC
Antifungal
23.6 µM

Target

P. vulgaris

Source & Reference

dbAMP CAFPdb Antifungipept

Other

li multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.1
Evidence 35 Activity

Activity

MIC
Antifungal
1.48 µM

Target

P. mirabilis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0
Evidence 36 Activity

Activity

MIC
Antifungal
11.8 µM

Target

S. typhi

Source & Reference

dbAMP CAFPdb Antifungipept

Other

ultiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (
Evidence 37 Activity

Activity

MIC
Antifungal
0.37 µM

Target

A. cinerea

Source & Reference

dbAMP CAFPdb Antifungipept

Other

lis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (MIC 23.6 uM).
Evidence 38 Activity

Activity

MIC
Antifungal
23.6 µM

Target

C. neoformans

Source & Reference

dbAMP CAFPdb Antifungipept

Other

i (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (MIC 23.6 uM).
Evidence 39 Activity

Activity

MIC
Antiparasitic
0.18-2.95 µM

Target

Staphylococcus aureus multiple strains

Source & Reference

NA

Other

Active against Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM),
Evidence 40 Activity

Activity

MIC
Antiparasitic
2.95 µM

Target

Staphylococcus epidermidis

Source & Reference

NA

Other

Active against Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E.
Evidence 41 Activity

Activity

MIC
Antiparasitic
0.09 µM

Target

Staphylococcus haemolyticus

Source & Reference

NA

Other

gainst Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes
Evidence 42 Activity

Activity

MIC
Antiparasitic
0.74 µM

Target

N. asteroids

Source & Reference

NA

Other

strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gr
Evidence 43 Activity

Activity

MIC
Antiparasitic
2.95 µM

Target

E. facalis

Source & Reference

NA

Other

S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 u
Evidence 44 Activity

Activity

MIC
Antiparasitic
1.48 µM

Target

E. faecium

Source & Reference

NA

Other

uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumanni
Evidence 45 Activity

Activity

MIC
Antiparasitic
0.74 µM

Target

P. acnes ATCC11827

Source & Reference

NA

Other

0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (M
Evidence 46 Activity

Activity

MIC
Antiparasitic
11.8 µM

Target

Klebsiella oxytoca

Source & Reference

NA

Other

facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC
Evidence 47 Activity

Activity

MIC
Antiparasitic
1.48 µM

Target

A. baumannii

Source & Reference

NA

Other

IC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strai
Evidence 48 Activity

Activity

MIC
Antiparasitic
0.74 µM

Target

Stenotrophomonas maltophilia

Source & Reference

NA

Other

827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli
Evidence 49 Activity

Activity

MIC
Antiparasitic
2.95 µM

Target

Stenotrophomonas maltophilia

Source & Reference

NA

Other

ytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.9
Evidence 50 Activity

Activity

MIC
Antiparasitic
1.48-5.9 µM

Target

Pseudomonas aeruginosa multiple strains

Source & Reference

NA

Other

, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.
Evidence 51 Activity

Activity

MIC
Antiparasitic
0.74-2.95 µM

Target

Escherichia coli multiple strains

Source & Reference

NA

Other

0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabili
Evidence 52 Activity

Activity

MIC
Antiparasitic
1.48-5.9 µM

Target

Klebsiella pneumoniae multiple strains

Source & Reference

NA

Other

ruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi
Evidence 53 Activity

Activity

MIC
Antiparasitic
23.6 µM

Target

P. vulgaris

Source & Reference

NA

Other

li multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.1
Evidence 54 Activity

Activity

MIC
Antiparasitic
1.48 µM

Target

P. mirabilis

Source & Reference

NA

Other

74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0
Evidence 55 Activity

Activity

MIC
Antiparasitic
11.8 µM

Target

S. typhi

Source & Reference

NA

Other

ultiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (
Evidence 56 Activity

Activity

MIC
Antiparasitic
0.37 µM

Target

A. cinerea

Source & Reference

NA

Other

lis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (MIC 23.6 uM).
Evidence 57 Activity

Activity

MIC
Antiparasitic
23.6 µM

Target

C. neoformans

Source & Reference

NA

Other

i (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (MIC 23.6 uM).
Evidence 58 Activity

Activity

MIC
Antiviral
0.18-2.95 µM

Target

Staphylococcus aureus multiple strains

Source & Reference

NA

Other

Active against Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM),
Evidence 59 Activity

Activity

MIC
Antiviral
2.95 µM

Target

Staphylococcus epidermidis

Source & Reference

NA

Other

Active against Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E.
Evidence 60 Activity

Activity

MIC
Antiviral
0.09 µM

Target

Staphylococcus haemolyticus

Source & Reference

NA

Other

gainst Gram+ S. aureus multiple strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes
Evidence 61 Activity

Activity

MIC
Antiviral
0.74 µM

Target

N. asteroids

Source & Reference

NA

Other

strains (MIC 0.18-2.95 uM), S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gr
Evidence 62 Activity

Activity

MIC
Antiviral
2.95 µM

Target

E. facalis

Source & Reference

NA

Other

S. epidermidis (MIC 2.95 uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 u
Evidence 63 Activity

Activity

MIC
Antiviral
1.48 µM

Target

E. faecium

Source & Reference

NA

Other

uM), S. haemolyticus (MIC 0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumanni
Evidence 64 Activity

Activity

MIC
Antiviral
0.74 µM

Target

P. acnes ATCC11827

Source & Reference

NA

Other

0.09 uM), N. asteroids (MIC 0.74 uM), E. facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (M
Evidence 65 Activity

Activity

MIC
Antiviral
11.8 µM

Target

Klebsiella oxytoca

Source & Reference

NA

Other

facalis (MIC 2.95 uM), E. faecium (MIC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC
Evidence 66 Activity

Activity

MIC
Antiviral
1.48 µM

Target

A. baumannii

Source & Reference

NA

Other

IC 1.48 uM), P. acnes ATCC11827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strai
Evidence 67 Activity

Activity

MIC
Antiviral
0.74 µM

Target

Stenotrophomonas maltophilia

Source & Reference

NA

Other

827 (MIC 0.74 uM), Gram- K. oxytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli
Evidence 68 Activity

Activity

MIC
Antiviral
2.95 µM

Target

Stenotrophomonas maltophilia

Source & Reference

NA

Other

ytoca (MIC 11.8 uM), A. sobria, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.9
Evidence 69 Activity

Activity

MIC
Antiviral
1.48-5.9 µM

Target

Pseudomonas aeruginosa multiple strains

Source & Reference

NA

Other

, A. baumannii (MIC 1.48 uM), S. maltophilia (MIC 0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.
Evidence 70 Activity

Activity

MIC
Antiviral
0.74-2.95 µM

Target

Escherichia coli multiple strains

Source & Reference

NA

Other

0.74 uM), S. maltophilia (MIC 2.95 uM), P. aeruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabili
Evidence 71 Activity

Activity

MIC
Antiviral
1.48-5.9 µM

Target

Klebsiella pneumoniae multiple strains

Source & Reference

NA

Other

ruginosa multiple strains (MIC 1.48-5.9 uM), E. coli multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi
Evidence 72 Activity

Activity

MIC
Antiviral
23.6 µM

Target

P. vulgaris

Source & Reference

NA

Other

li multiple strains (MIC 0.74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.1
Evidence 73 Activity

Activity

MIC
Antiviral
1.48 µM

Target

P. mirabilis

Source & Reference

NA

Other

74-2.95 uM), K. pneumoniae multiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0
Evidence 74 Activity

Activity

MIC
Antiviral
11.8 µM

Target

S. typhi

Source & Reference

NA

Other

ultiple strains (MIC 1.48-5.9 uM), P. vulgaris (MIC 23.6 uM), P. mirabilis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (
Evidence 75 Activity

Activity

MIC
Antiviral
0.37 µM

Target

A. cinerea

Source & Reference

NA

Other

lis (MIC 1.48 uM), S. typhi (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (MIC 23.6 uM).
Evidence 76 Activity

Activity

MIC
Antiviral
23.6 µM

Target

C. neoformans

Source & Reference

NA

Other

i (MIC 11.8 uM), and fungi C. albicans 2 strains (0.18-5.9 uM), A. cinerea (MIC 0.37 uM), C. neoformans (MIC 23.6 uM).
Evidence 77 Activity

Activity

13% Hemolysis
Toxicity
31.5 µM
Hemolytic Cytotoxic
13% Hemolysis | 31.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Molecular cloning and characterization of novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus. | Dev Comp Immunol | 2011
Evidence 78 Activity

Activity

9% Hemolysis
Toxicity
15.7 µM
Hemolytic Cytotoxic
9% Hemolysis | 15.7 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Molecular cloning and characterization of novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus. | Dev Comp Immunol | 2011
Evidence 79 Activity

Activity

6% Hemolysis
Toxicity
6.30 µM
Hemolytic Cytotoxic
6% Hemolysis | 6.30 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Molecular cloning and characterization of novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus. | Dev Comp Immunol | 2011
Evidence 80 Activity

Activity

4% Hemolysis
Toxicity
3.15 µM
Hemolytic Cytotoxic
4% Hemolysis | 3.15 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Molecular cloning and characterization of novel cathelicidin-derived myeloid antimicrobial peptide from Phasianus colchicus. | Dev Comp Immunol | 2011
Evidence 81 Activity

Target

Cutibacterium acnes

Source & Reference

DBAASP
Evidence 82 Hemolysis

Source & Reference

APD_complete HemoPI PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.